| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.42T | 2.59T | 2.39T | 2.62T | 2.28T | 1.61T |
| Gross Profit | 414.27B | 469.34B | 413.27B | 510.15B | 453.43B | 233.18B |
| EBITDA | 302.06B | 368.99B | 319.11B | 419.76B | 371.46B | 172.12B |
| Net Income | 229.19B | 477.71B | 228.60B | 1.01T | 1.01T | 139.23B |
Balance Sheet | ||||||
| Total Assets | 4.98T | 4.32T | 4.25T | 3.78T | 3.08T | 2.13T |
| Cash, Cash Equivalents and Short-Term Investments | 221.19B | 156.01B | 156.16B | 204.82B | 233.02B | 107.51B |
| Total Debt | 1.23T | 738.46B | 913.80B | 694.09B | 808.30B | 954.87B |
| Total Liabilities | 2.03T | 1.35T | 1.56T | 1.25T | 1.32T | 1.46T |
| Stockholders Equity | 2.89T | 2.92T | 2.65T | 2.48T | 1.71T | 625.33B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 304.25B | 65.13B | 626.49B | 315.04B | 57.25B |
| Operating Cash Flow | 0.00 | 510.75B | 401.41B | 824.85B | 507.76B | 159.34B |
| Investing Cash Flow | 0.00 | -59.78B | -285.63B | -251.98B | -142.59B | -15.65B |
| Financing Cash Flow | 0.00 | -427.75B | -163.42B | -582.19B | -243.52B | -126.70B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥1.65T | 10.15 | 11.32% | 5.12% | -2.96% | -10.12% | |
79 Outperform | ¥2.35T | 6.29 | 10.90% | 5.81% | 0.36% | -14.86% | |
77 Outperform | ¥2.48T | 11.76 | 10.82% | 6.25% | -3.22% | -13.20% | |
76 Outperform | ¥176.74B | 5.06 | 13.08% | 3.75% | -7.72% | 27.03% | |
76 Outperform | ¥193.10B | 7.21 | ― | 4.08% | -10.66% | -17.73% | |
65 Neutral | ¥13.11B | 1,812.20 | ― | 5.77% | 3.22% | -87.75% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |